Israeli tank fires on Palestinians waiting for aid in Gaza; 45 killed, says health ministry
Israeli tank shellfire killed at least 45 Palestinians and wounded dozens of others as they were waiting for aid trucks in Khan Younis in the southern Gaza Strip, the territory's health ministry said.
According to medics, the residents said that the Israeli tanks fired shells against crowds of desperate Palestinians awaiting aid trucks along the main eastern road in Khan Younis.
The medics are also expecting the number of fatalities to rise as many of the wounded were in critical condition, reported Reuters.
A ministry statement added that the Nasser Hospital, where the casualties were rushed to, had been overwhelmed by the number of deaths and injuries.
AP reported that the circumstances of the killings were not clear. It did not seem to be related to a new Israeli- and US-supported aid delivery network that rolled out last month and has been disrupted by controversy and violence.
Palestinians claim that Israeli forces have opened fire on crowds on multiple occasions. Especially, when these people are trying to reach food distribution points run by a separate US and Israeli-backed aid group since the centres opened last month. Local health officials say scores have been killed and hundreds wounded, AP reported.
The Israeli military has acknowledged firing warning shots at people, claiming that some people had approached its forces in a suspicious manner. Israel defends its new system, saying it is designed to prevent Hamas from siphoning off aid to fund its militant activities.
UN agencies and major aid groups deny the possibility of any major diversion of aid and have outrightly rejected the new system, saying it can't meet the increasing needs in Gaza. They also said that it violates humanitarian principles by giving the entire power to Israel to determine who has access to aid. Experts have warned of widespread famine in Gaza, reported AP.
The UN-run network has delivered aid across Gaza throughout the 20-month Israel-Hamas war, but has faced major barriers since Israel loosened a total blockade it had imposed from early March until mid-May. UN officials say Israeli military restrictions, a breakdown of law and order, and widespread looting are making it difficult to deliver the aid that Israel has allowed in, said AP.
Israel's military campaign since October 2023 has killed over 55,300 Palestinians, including both civilians and combatants. Out of the deceased people, more than half of them are women and children, according to Gaza's Health Ministry, AP reported.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
Miracle! 31-year-old brain dead woman delivers baby. Here's what doctor is saying
A 31-year-old woman, who was declared brain dead and has been on life support since February, has delivered a baby in Georgia. The mother of the woman named Adriana Smith revealed that the baby was born prematurely by an emergency cesarean section early on Friday. She was about six months into her pregnancy. The baby, named Chance, weighs about 1 pound and 13 ounces and is in the neonatal intensive care unit, AP reported quoting Atlanta media outlet. Adam Smith's mother April Newkirk told WXIA-TV the baby has been fighting and is expected to be okay. Newkirk said Smith would be taken off of life support on Tuesday. Emory University Hospital determined she had blood clots in her brain and she was declared brain-dead. She was eight weeks pregnant, according to WXIA. Smith's family said Emory doctors told them they were not allowed to remove the devices keeping her breathing because state law bans abortion after cardiac activity can be detected — generally around six weeks into pregnancy, AP reported. Georgia Republican Attorney General Chris Carr later issued a statement saying the law did not require medical professionals to keep a woman declared brain dead on life support. Live Events Newkirk said Smith loved being a nurse at Emory. She also has a 7-year-old son. Her family celebrated her 31st birthday Sunday with several advocacy groups. Newkirk did not speak at the event. FAQs Q1. Can a woman deliver baby while being brain dead? A1. A woman in Georgia delivered baby even though she is brain dead. Q2. What is name of brain dead woman? A2. The name of brain dead woman is Adam Smith.


NDTV
5 hours ago
- NDTV
Gaza Health Care At "Breaking Point" As Fuel Runs Out: WHO
The World Health Organization on Tuesday pleaded for fuel to be allowed into Gaza to keep its remaining hospitals running, warning the Palestinian territory's health system was at "breaking point". "For over 100 days, no fuel has entered Gaza and attempts to retrieve stocks from evacuation zones have been denied," said Rik Peeperkorn, the WHO's representative in the Palestinian territories. "Combined with critical supply shortages, this is pushing the health system closer to the brink of collapse." Peeperkorn said only 17 of Gaza's 36 hospitals were currently minimally to partially functional. They have a total of around 1,500 beds -- around 45 percent fewer than before the conflict began. He said all hospitals and primary health centres in north Gaza were currently out of service. In Rafah in southern Gaza, health services are provided through the Red Cross field hospital and two partially-functioning medical points. Speaking from Jerusalem, he said the 17 partially functioning hospitals and seven field hospitals were barely running on a minimum amount of daily fuel and "will soon have none left". "Without fuel, all levels of care will cease, leading to more preventable deaths and suffering." Hospitals were already switching between generators and batteries to power ventilators, dialysis machines and incubators, he said, and without fuel, ambulances cannot run and supplies cannot be delivered to hospitals. Furthermore, field hospitals are entirely reliant on generators, and without electricity, the cold chain for keeping vaccines would fail. The war was triggered by an unprecedented Hamas attack on Israel on October 7, 2023, which resulted in the deaths of 1,219 people, according to official Israeli figures. The health ministry in Hamas-run Gaza said on Monday that 5,194 people have been killed since Israel resumed strikes on the territory on March 18 following a truce. The overall death toll in Gaza since the war broke out on October 7, 2023 has reached 55,493 people, according to the health ministry. "People often ask when Gaza is going to be out of fuel; Gaza is already out of fuel," said WHO trauma surgeon and emergency officer Thanos Gargavanis, speaking from the Strip. "We are walking already the fine line that separates disaster from saving lives. The shrinking humanitarian space makes every health activity way more difficult than the previous day." (Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)


Mint
5 hours ago
- Mint
Eli Lilly to acquire gene-editing biotech company Verve Therapeutics for $1.3 billion. Here's why
US-based multinational pharmaceutical giant Eli Lilly & Co., on Tuesday, 17 June 2025, announced its plans to acquire gene-editing biotech firm Verve Therapeutics Inc. for $1.3 billion as the big pharma company eyes expansion in experimental medicine for long-term growth, reported the news agency Bloomberg. According to the agency report, Eli Lilly & Co. will pay up to $13.50 per share for the acquisition deal. The breakdown of the deal will be that Eli Lilly & Co. will pay $10.50 per share in cash as well as a non-tradeable contingent value right that entitles the holder to receive as much as $3 extra per share. The transaction is expected to close in the third quarter of the current year, reported the news agency, citing the company. Verve Therapeutics shares skyrocketed 75.12% to $10.99 at the US stock market open at 9:38 a.m. (EDT), compared to $6.27 at the previous market close. However, pharma major Eli Lilly & Co. shares are trading 1.45% lower on Wall Street at $795.84 as of 9:40 a.m. (EDT), compared to $807.58 at the previous stock market close. The US big pharma company Eli Lilly & Co.'s revenues are centred around its iconic weight-loss drug, Zepbound, as the company prepares for the medicine's patent to expire. The news agency reported that the company has been able to target experimental medicines that are still far from the market. In this area, price tags are usually smaller than for therapies that have already undergone multiple patient trials. The long-term return on such early-stage deals can be far larger. In January 2025, Eli Lilly & Co. agreed to pay up to $2.5 billion for a cancer medicine which was being tested by Scorpion Therapeutics Inc., as per the agency report. Further in May, the company announced a plan to buy SiteOne Therapeutics Inc., a biotech firm developing pain medicines, for nearly $1 billion. Eli Lilly & Co. was reportedly in collaboration with Verve Therapeutics on its experimental gene-editing program for reducing lipoprotein, which is a risk factor for plaque buildup in human arteries. This acquisition deal will give Eli Lilly & Co. full control of the program, as the company shows confidence in its gene editing drug, which is a cutting-edge technology in the market, according to the report. However, this technology has struggled to attract investors recently, in part because it's expensive to make and aimed at providing one-time cures for rare diseases that may not be lucrative. Verve is a rare example of a gene editing company targeting a disease that affects a large population and offering better commercial prospects. Its approach, which uses tiny balls of fat to deliver the treatment, is less expensive to make than other gene therapies. Ruth Gimeno, the Vice President for diabetes and metabolic research and development at Eli Lilly & Co., told the news agency that the experimental therapy could be the first to edit genes inside a living body that's targeted to a broad population of patients.